

Z100895 by Applied Biological Materials is a recombinant human VEGF-165 expressed in E. coli, supplied as a lyophilized non-glycosylated homodimer (~38.2 kDa, 2 × 165 aa) at >98% purity. VEGF-165 is the most potent and abundant secreted VEGF isoform, driving HUVEC proliferation at ED50 <10 ng/ml via VEGFR2/KDR — the reference antigen for bevacizumab and anti-VEGF therapeutic validation.